
Kyle D. O'Connor
@oconnkyle
CTRA Lab - Yale, Alumnus | Georgetown '21 | Duke '20
ID: 1157367541347553283
02-08-2019 19:08:19
115 Tweet
46 Followers
75 Following









Incredibly excited to share my first senior author publication in JACC Journals! How does risk prediction impact care for heart failure patients in the ICU? #JACCHF 🧵 sciencedirect.com/science/articl…


What’s the state of current clinical support in kidney medicine? bit.ly/444PGva Kyle D. O'Connor F. Perry Wilson, MD MSCE Yale Nephrology Kenar Jhaveri


Our latest paper in European Society of Cardiology Journals EHJ Editor-in-Chief #EHJ: The results of the PROMPT-AHF trial! Tariq Ahmad MD MPH F. Perry Wilson, MD MSCE Nihar Desai MD MPH Lama Ghazi, MD PhD Kyle D. O'Connor Ralph J. Riello III, PharmD, BCPS Yale Cardiology Yale Internal Medicine academic.oup.com/eurheartj/adva…

🚨Our study on longitudinal outcomes following #COVID-associated AKI is now out. Yale Nephrology #CTRA jamanetwork.com/journals/jamai…



📸‼️Abinet Aklilu presenting the results of Kidney Action Team Randomized Trial at the High-Impact Clinical Trials session!! Would rapid, personalized recs within 1 hr of AKI from a physician & pharmacist improve outcomes? 👀 F. Perry Wilson, MD MSCE thread for a presentation breakdown!


Welcome to our new Director, CDC Director Susan Monarez! We look forward to your leadership in preventing disease, addressing global health threats, and advancing President Donald J. Trump 's and Secretary Kennedy 's mission to Make America Healthy Again. Read the full Press Release at bit.ly/44Zht3v


ICYMI: On Tuesday, Secretary Kennedy and Dr. Marty Makary, joined by Markwayne Mullin, announced U.S. FDA’s latest action to protect Americans from dangerous, illegal opioids: recommending a scheduling action to control certain 7-hydroxymitragynine (7-OH) products, which are increasingly

